Hayashida Jon K. 4
4 · STAAR SURGICAL CO · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Hayashida Jon K.
VP, Global Clinical, Medical
Transactions
- Exercise/Conversion
Common Stock
2021-03-01$35.98/sh+16,000$575,680→ 26,794 total - Sale
Common Stock
2021-03-01$105.43/sh−16,000$1,686,880→ 10,794 total - Exercise/Conversion
Common Stock Options
2021-03-01−16,000→ 12,026 totalExercise: $35.98From: 2020-03-14Exp: 2029-03-13→ Common Stock (16,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.86 to $106.19, inclusive.
- [F2]The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2023.